go to medicines.ie homepage
  • Home  |  
  • About  |  
  • Links  |  
  • Help
Font Size
Search for:  
select
select
  • SPCs and PILs
  • SPCs Only
  • PILs Only
  Advanced Search
  • What's
    New
      
  • Browse
    Medicines
      
  • Browse
    Active Ingredients
      
  • Browse
    Companies
      
  • Codes
    of Practice
      
  • Adverse
    Reaction Reporting

McNeil Healthcare (Ireland) Ltd

McNeil Healthcare (Ireland) Ltd
Airton Road, Tallaght, Dublin 24, Ireland
Telephone: +353 1 466 5200
Fax: +353 1 466 5316


Summary of Product Characteristics last updated on medicines.ie: 02/07/2010
SPC Anusol HC Suppositories

Table of Contents

  • 1. NAME OF THE MEDICINAL PRODUCT
  • 2. QUALITATIVE AND QUANTITATIVE COMPOSITION
  • 3. PHARMACEUTICAL FORM
  • 4. CLINICAL PARTICULARS
  • 4.1 Therapeutic indications
  • 4.2 Posology and method of administration
  • 4.3 Contraindications
  • 4.4 Special warnings and precautions for use
  • 4.5 Interaction with other medicinal products and other forms of interaction
  • 4.6 Pregnancy and lactation
  • 4.7 Effects on ability to drive and use machines
  • 4.8 Undesirable effects
  • 4.9 Overdose
  • 5. PHARMACOLOGICAL PROPERTIES
  • 5.1 Pharmacodynamic properties
  • 5.2 Pharmacokinetic properties
  • 5.3 Preclinical safety data
  • 6. PHARMACEUTICAL PARTICULARS
  • 6.1 List of excipients
  • 6.2 Incompatibilities
  • 6.3 Shelf life
  • 6.4 Special precautions for storage
  • 6.5 Nature and contents of container
  • 6.6 Special precautions for disposal and other handling
  • 7. MARKETING AUTHORISATION HOLDER
  • 8. MARKETING AUTHORISATION NUMBER(S)
  • 9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
  • 10. DATE OF REVISION OF THE TEXT


Go to top of the page
1. NAME OF THE MEDICINAL PRODUCT

Anusol HC Suppositories


Go to top of the page
2. QUALITATIVE AND QUANTITATIVE COMPOSITION

Each 2.8g suppository contains:

Hydrocortisone Acetate 10mg

Benzyl Benzoate 33mg

Bismuth Oxide 24mg

Balsam Peru 49mg

Zinc Oxide 296mg

Bismuth Subgallate 59mg

For a full list of excipients see section 6.1


Go to top of the page
3. PHARMACEUTICAL FORM

Suppositories.

Off white suppositories .


Go to top of the page
4. CLINICAL PARTICULARS

Go to top of the page
4.1 Therapeutic indications

Anusol HC Suppositories are indicated for the symptomatic relief of external and internal haemorrhoids, proctitis, cryptitis, anal fissures, pruritus ani and perianal sinuses. Also indicated post-operatively in ano-rectal surgical procedures.


Go to top of the page
4.2 Posology and method of administration

Intrarectal

Adults

Remove wrapper and insert one suppository into the anus at night, in the morning and after each evacuation, up to a maximum of three a day.

Not to be taken orally.

Elderly (over 65 years)

As for adults

Children

Not recommended


Go to top of the page
4.3 Contraindications

Tubercular, fungal, bacterial and viral lesions including herpes simplex, vaccinia and varicella.

History of sensitivity to any of the constituents.


Go to top of the page
4.4 Special warnings and precautions for use

As with all products containing topical steroids the possibility of systemic absorption should be borne in mind.

Prolonged or excessive use may produce systemic corticosteroid effects and use for periods longer than seven days is not recommended.

The product should be discontinued and the patient advised to consult a medical practitioner if symptoms do not improve or worsen if rectal bleeding occurs.


Go to top of the page
4.5 Interaction with other medicinal products and other forms of interaction

Concurrent use with other corticosteroid preparations, either topically or orally, may increase the likelihood of systemic effects.


Go to top of the page
4.6 Pregnancy and lactation

Should not be used during pregnancy or lactation unless considered essential by the physician.

There is inadequate evidence of safety in human pregnancy and there may be a very small risk of cleft palate and intrauterine growth retardation as well as suppression of the neonatal hypothalamic –pituitary-adrenal axis. There is evidence of harmful effects in animals.


Go to top of the page
4.7 Effects on ability to drive and use machines

Not applicable


Go to top of the page
4.8 Undesirable effects

Rarely, sensitivity reactions. Patients may occasionally experience transient burning on application, especially if the anoderm is not intact.


Go to top of the page
4.9 Overdose

If swallowed, fever, nausea, vomiting, stomach cramps and diarrhoea may develop 3-12 hours after ingestion.

Hydrocortisone does not normally produce toxic effects in an acute single overdose.

Treatment of a large acute overdosage should include gastric lavage, purgation with magnesium sulphate and complete bed rest. If necessary, give oxygen and general supportive measures. Methaemoglobinaemia should be treated by intravenous methylthioninium chloride.


Go to top of the page
5. PHARMACOLOGICAL PROPERTIES

Go to top of the page
5.1 Pharmacodynamic properties

Anusol HC Suppositories provide antiseptic, astringent, emollient and vascular decongestant properties. In addition, hydrocortisone exerts an anti-inflammatory effect.

Bismuth oxide, zinc oxide and bismuth subgallate exert a protective action on mucous membranes and raw surfaces. They are mildly astringent and are reported to have antiseptic properties.

Balsam Peru has protective properties and a very mild antiseptic action by virtue of its content of cinnamic and benzoic acids. It is believed to promote the growth of epithelial cells. Benzyl benzoate is used as a solubilising agent and has mild antiseptic and preservative properties.

Hydrocortisone acetate has the general properties of hydrocortisone and the anti-inflammatory action is of primary interest in this product.


Go to top of the page
5.2 Pharmacokinetic properties

It is well known that topically applied corticosteroids can be absorbed percutaneously. This appears to be more likely upon repeated or prolonged use.

The other active ingredients in Anusol HC Suppositories exert their therapeutic effect without being abosorbed into the systemic circulation. These observations are supported by evidence from various studies and reviews.


Go to top of the page
5.3 Preclinical safety data

Pre-clinical safety data do not add anything of further significance to the prescriber.


Go to top of the page
6. PHARMACEUTICAL PARTICULARS

Go to top of the page
6.1 List of excipients

Each suppository contains:

Kaolin light

Hard fat (Suppocire BS2 pastilles)


Go to top of the page
6.2 Incompatibilities

None applicable


Go to top of the page
6.3 Shelf life

3 years


Go to top of the page
6.4 Special precautions for storage

Do not store above 25°C.


Go to top of the page
6.5 Nature and contents of container

Printed strip pack consisting of white opaque pvc/polythene laminated film. There are six suppositories in a strip and two strips (12 suppositories) in a box.


Go to top of the page
6.6 Special precautions for disposal and other handling

No special requirements.


Go to top of the page
7. MARKETING AUTHORISATION HOLDER

McNeil Healthcare (Ireland) Limited

Airton Road

Tallaght

Dublin 24

Ireland


Go to top of the page
8. MARKETING AUTHORISATION NUMBER(S)

PA 823/40/4


Go to top of the page
9. DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION

30 March 1990 / 30th March 2010


Go to top of the page
10. DATE OF REVISION OF THE TEXT

June 2010



Link to this document from your website:
http://www.medicines.ie/medicine/7263/SPC/Anusol+HC+Suppositories/

Document Links

 
  Link to this page
  View all medicines
from this company
Print this page
View document history
Bookmark and Share

Legal Categories

 
   Product subject to medical
prescription which may not
be renewed (A)
   Product subject to medical
prescription which may
be renewed (B)
   Product subject to
restricted prescription
(C)
   Supply through
general sale
   Supply through
pharmacy only

Active Ingredients

 
   Zinc Oxide
   Benzyl Benzoate
   Bismuth Oxide
   Bismuth Subgallate
   Balsam Peru
   Hydrocortisone Acetate

  • Terms & Conditions | 
  • Accessibility | 
  • Privacy Statement | 
  • Contact Us

Registered Address: Franklin House, 140 Pembroke Road, Dublin 4, Ireland
Registered Number: 254776
Tel: (353 1) 6603350 Fax: (353 1) 6686672 Email: info@ipha.ie

This website is certified by Health On the Net Foundation. Click to verify.

This site complies with the HONcode standard for trustworthy health information: verify here.

logo